Copyright
©The Author(s) 2021.
World J Hepatol. Oct 27, 2021; 13(10): 1215-1233
Published online Oct 27, 2021. doi: 10.4254/wjh.v13.i10.1215
Published online Oct 27, 2021. doi: 10.4254/wjh.v13.i10.1215
Figure 1 Pathogenesis of liver injury in coronavirus disease 2019.
ACE2: Angiotensin-converting enzyme 2; COVID-19: Coronavirus disease 2019; CLD: Chronic liver disease(s); DILI: Drug-induced liver injury; GI: Gastrointestinal; LRTI: Lower respiratory tract infection; LFTs: Liver function tests; SARS-CoV-2: Severe acute respiratory syndrome coronavirus-2; SIRS: Systemic inflammatory response syndrome; URTI: Upper respiratory tract infection.
- Citation: Omar AS, Kaddoura R, Orabi B, Hanoura S. Impact of COVID-19 pandemic on liver, liver diseases, and liver transplantation programs in intensive care units. World J Hepatol 2021; 13(10): 1215-1233
- URL: https://www.wjgnet.com/1948-5182/full/v13/i10/1215.htm
- DOI: https://dx.doi.org/10.4254/wjh.v13.i10.1215